Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome

OBJECTIVE: To evaluate the safety of an aerosolised surfactant, SF-RI 1, administered via nasal continuous positive airway pressure (nCPAP) and a prototype breath synchronisation device (AeroFact), to preterm infants with respiratory distress syndrome (RDS). DESIGN: Multicentre, open-label, dose-esc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jardine, Luke, Lui, Kei, Liley, Helen G, Schindler, Timothy, Fink, James, Asselin, Jeanette, Durand, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685619/
https://www.ncbi.nlm.nih.gov/pubmed/34112722
http://dx.doi.org/10.1136/archdischild-2021-321645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685619/
https://www.ncbi.nlm.nih.gov/pubmed/34112722
http://dx.doi.org/10.1136/archdischild-2021-321645

Ejemplares similares